This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06925/identifier/chemspider/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB06925/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06925/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB06925/identifier/pubchem-substance/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB06925/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06925
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB06925 n11:DB06925
dcterms:title
3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
adms:identifier
n9:13122508 n10:DB06925 n12:99443396 n13:242 n14:15991573
n3:IUPAC-Name
n4:271B5F58-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5F5E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5F5D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5F5A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5F5B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5F5C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5F56-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5F54-363D-11E5-9242-09173F13E4C5 n4:271B5F57-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5F55-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5F64-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5F65-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5F5F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5F60-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5F62-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5F61-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5F63-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5F6A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5F6C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5F6D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5F69-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5F68-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5F6B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5F59-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5F66-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5F67-363D-11E5-9242-09173F13E4C5